You are here

New takeover targets with hot biotech IPOs

New York

AFTER being overshadowed last year by the boom in big pharmaceutical mergers, biotechnology deals are kicking off 2015. The first large drug transaction of the year was Shire Plc's agreement on Sunday to buy rare-disease treatment developer NPS Pharmaceuticals Inc for US$5.2...

Market voices on: